- Home
- POAI vs BFRI Comparison
POAI vs BFRI Comparison
Compare POAI & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- BFRI
- Stock Information
- Founded
- POAI 2002
- BFRI 1997
- Country
- POAI United States
- BFRI United States
- Employees
- POAI N/A
- BFRI N/A
- Industry
- POAI Industrial Specialties
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- POAI Health Care
- BFRI Health Care
- Exchange
- POAI Nasdaq
- BFRI Nasdaq
- Market Cap
- POAI 8.9M
- BFRI 7.5M
- IPO Year
- POAI N/A
- BFRI 2021
- Fundamental
- Price
- POAI $1.09
- BFRI $0.83
- Analyst Decision
- POAI Hold
- BFRI Strong Buy
- Analyst Count
- POAI 1
- BFRI 1
- Target Price
- POAI N/A
- BFRI $7.00
- AVG Volume (30 Days)
- POAI 359.2K
- BFRI 80.1K
- Earning Date
- POAI 05-13-2025
- BFRI 05-14-2025
- Dividend Yield
- POAI N/A
- BFRI N/A
- EPS Growth
- POAI N/A
- BFRI N/A
- EPS
- POAI N/A
- BFRI N/A
- Revenue
- POAI $1,623,817.00
- BFRI $37,321,000.00
- Revenue This Year
- POAI $486.27
- BFRI $18.57
- Revenue Next Year
- POAI $65.50
- BFRI $20.17
- P/E Ratio
- POAI N/A
- BFRI N/A
- Revenue Growth
- POAI N/A
- BFRI 9.54
- 52 Week Low
- POAI $0.55
- BFRI $0.65
- 52 Week High
- POAI $3.06
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- POAI 48.65
- BFRI 48.57
- Support Level
- POAI $0.85
- BFRI $0.76
- Resistance Level
- POAI $1.44
- BFRI $0.87
- Average True Range (ATR)
- POAI 0.12
- BFRI 0.07
- MACD
- POAI -0.01
- BFRI 0.01
- Stochastic Oscillator
- POAI 40.68
- BFRI 81.02
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.